PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas (original) (raw)

Abstract

The phosphoinositide 3-kinase (PI3-kinase) signaling pathway is frequently aberrantly activated in glioblastoma multiforme (GM) by mutation or loss of the 3′ phospholipid phosphatase PTEN. PTEN abnormalities result in inappropriate signaling to downstream molecules including protein kinase B (PKB/Akt), and mammalian target of rapamycin (mTOR). PI3-kinase activation increases resistance to radiation-induced cell death; conversely, PI3-kinase inhibition enhances the sensitivity of tumors to radiation. The effects of LY294002, a biochemical inhibitor of PI3-kinase, on the response to radiation were examined in the PTEN mutant glioma cell line U251 MG. Low doses of LY294002 sensitized U251 MG to clinically relevant doses of radiation. In contrast to LY294002, rapamycin, an inhibitor of mTOR, did not result in radiosensitization. We demonstrate that among multiple known targets of LY294002, PI3-kinase is the most likely molecule responsible for LY294002-induced radiosensitization. Furthermore, using a myristoylated PKB/Akt construct, we identified PKB/Akt as the downstream molecule that mediates the synergistic cytotoxicity between LY294002 and radiation. Thus PI3-kinase dysregulation may contribute to the notable radioresistance of GM tumors and inhibition of PKB/Akt offers an excellent target to enhance radiosensitivity.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

GM:

glioblastoma multiforme

PI3-kinase:

phosphatidylinositol 3-kinase

PKB:

protein kinase B

PTEN:

phosphatase and tensin homologue deleted on chromosome ten

SEM:

standard error of the mean

References

Download references

Author information

Authors and Affiliations

  1. Departments of Radiation Oncology, The University of California, USA
    Jean L. Nakamura, Amelia Karlsson, Nils D. Arvold, Alexander R. Gottschalk & Daphne A. Haas-Kogan
  2. Brain Tumor Research Center and Neurosurgery, The University of California, USA
    Russell O. Pieper, David Stokoe & Daphne A. Haas-Kogan
  3. Cancer Research Center, The University of California, San Francisco, CA, USA
    David Stokoe
  4. Department of Radiation Oncology and Comprehensive Cancer Center, UCSF, 1600 Divisadero St. Suite H-1031, San Francisco, CA, 94143, USA
    Daphne A. Haas-Kogan

Authors

  1. Jean L. Nakamura
    You can also search for this author inPubMed Google Scholar
  2. Amelia Karlsson
    You can also search for this author inPubMed Google Scholar
  3. Nils D. Arvold
    You can also search for this author inPubMed Google Scholar
  4. Alexander R. Gottschalk
    You can also search for this author inPubMed Google Scholar
  5. Russell O. Pieper
    You can also search for this author inPubMed Google Scholar
  6. David Stokoe
    You can also search for this author inPubMed Google Scholar
  7. Daphne A. Haas-Kogan
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toDaphne A. Haas-Kogan.

Rights and permissions

About this article

Cite this article

Nakamura, J.L., Karlsson, A., Arvold, N.D. et al. PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas.J Neurooncol 71, 215–222 (2005). https://doi.org/10.1007/s11060-004-1718-y

Download citation

Keywords